Although the PKC inhibitors AEB071 or AHT956 inhibited MAPK signaling and induced G1 arrest in GNAQ/11-mutated UM cells, they failed to induce UM tumor regressions in xenograft models. This evidence concerns the gene PRRT2 and neoplasm.